CompletedNot Applicable

ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

United States108 participantsStarted 2007-05

Plain-language summary

This registry will evaluate long-term safety and efficacy of deferasirox in children with transfusional iron overload.

Who can participate

Age range2 Years – 5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * History of transfusion-dependent anemia. * History of iron overload Exclusion Criteria: * Patients with non-transfusional hemosiderosis. Other protocol-defined inclusion/exclusion criteria may apply.

What they're measuring

Safety - renal and hepatic function monitoring.

Timeframe: 5 years

Trial details

NCT IDNCT00466063

SponsorNovartis Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-07

View on ClinicalTrials.gov More Anemia trials